Stock Information
Viking Therapeutics Inc (VKTX)
Ticker Symbol: VKTX
Exchange: NASDAQ
Sector: Biotechnology
Market Cap: $3,825.15 mil
Piotroski score: 2
PE Ratio: N/A
EPS (TTM): -3.183
Revenue (TTM): $0.00 M
Dividend Yield: N/A%
ROE: -48.04%
Latest News
-
Viking Therapeutics Completed Enrollment in Phase 3 VANQUISH-2 Trial of VK2735
Thu, Mar 26, 2026 7:09 AM
Key Financials
Financial data not available